These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11781066)

  • 1. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
    Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.
    van Herpen CM; van der Laak JA; de Vries IJ; van Krieken JH; de Wilde PC; Balvers MG; Adema GJ; De Mulder PH
    Clin Cancer Res; 2005 Mar; 11(5):1899-909. PubMed ID: 15756016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.
    Mickel RA; Kessler DJ; Taylor JM; Lichtenstein A
    Cancer Res; 1988 Sep; 48(17):5017-22. PubMed ID: 3409231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of poor CD3 response in head and neck cancer.
    Shibuya TY; Nugyen N; McLaren CE; Li KT; Wei WZ; Kim S; Yoo GH; Rogowski A; Ensley J; Sakr W
    Clin Cancer Res; 2002 Mar; 8(3):745-51. PubMed ID: 11895904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
    Milanovich MR; Snyderman CH; Wagner R; Johnson JT
    Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
    Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
    Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
    Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
    Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma.
    Fattorossi A; Battaglia A; Ferrandina G; Coronetta F; Legge F; Salutari V; Scambia G
    Cancer; 2004 Apr; 100(7):1418-28. PubMed ID: 15042676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of metastatic lymph node topography in head and neck squamous cell carcinomas.
    Tao L; Lefèvre M; Callard P; Périé S; Bernaudin JF; St Guily JL
    Otolaryngol Head Neck Surg; 2006 Sep; 135(3):445-50. PubMed ID: 16949980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA; Ramey WG; Paderon H; Miller RE
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
    Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
    J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma.
    Croce MV; Rabassa ME; Pereyra A; Segal-Eiras A
    Head Neck; 2008 May; 30(5):647-57. PubMed ID: 18302268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
    Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
    Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
    Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.